Cited by 1,106HIV Research and TreatmentHIV-related health complications and treatmentsHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Open access

Sandler, Netanya G., Wand, Handan, Roque, Annelys, Law, Matthew, Nason, Martha C., Nixon, Daniel E., Pedersen, Court, Ruxrungtham, Kiat, Lewin, Sharon R., Emery, Sean, Neaton, James D., Brenchley, Jason M., Deeks, Steven G., Sereti, Irini, Douek, Daniel C.·2011·The Journal of Infectious Diseases

DOI 10.1093/infdis/jiq118PMC PMC3071127

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Chronic human immunodeficiency virus (HIV) infection is associated with intestinal permeability and microbial translocation that contributes to systemic immune activation, which is an independent predictor of HIV disease progression. The association of microbial translocation with clinical outcome remains unknown. METHODS: This nested case-control study included 74 subjects who died, 120 of whom developed cardiovascular disease and 81 of whom developed AIDS during the Strategies for Management of Anti-Retroviral Therapy (SMART) study with matched control subjects. Intestinal fatty acid binding protein (I-FABP), lipopolysaccharide (LPS), soluble CD14 (sCD14), endotoxin core antibody (EndoCAb), and 16S ribosomal DNA (rDNA) were measured in baseline plasma samples. RESULTS: Subjects with the highest quartile of sCD14 levels had a 6-fold higher risk of death than did those in the lowest quartile (95% confidence interval, 2.2-16.1; P<.001), with minimal change after adjustment for inflammatory markers, CD4(+) T cell count, and HIV RNA level. No other marker was significantly associated with clinical outcomes. I-FABP, LPS, and sCD14 were increased and EndoCAb was decreased in study subjects, compared with healthy volunteers. sCD14 level correlated with levels of IL-6, C-reactive protein, serum amyloid A and D-dimer. CONCLUSIONS: sCD14, a marker of monocyte response to LPS, is an independent predictor of mortality in HIV infection. Therapeutic attenuation of innate immune activation may improve survival in patients with HIV infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/infdis/jiq118

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citation
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836
Self-citation
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citation
Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection
Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404
LPS, TLR4 and infectious disease diversity
Miller, S., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 1,059
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Self-citation
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
Deeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803
Self-citation
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
Jiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598
Self-citation

Show all 50 references

Sorted by citations

Items 401–500 of 1,000

Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy
Thurman, M., Johnson, S. D., Acharya, A., Pallikkuth, S., Mahesh, M., & Byrareddy, S. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583934 · Cited by 35
Tree-aggregated predictive modeling of microbiome data
Bien, J., Yan, X., Simpson, L., & Müller, C. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-93645-3 · Cited by 31
Human immunodeficiency virus and menopause
Kanapathipillai, R., Hickey, M., & Giles, M. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318282aa57 · Cited by 32
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
Jespersen, S., Pedersen, K. K., Anesten, B., Zetterberg, H., Fuchs, D., Gisslén, M., Hagberg, L., Trøseid, M., & Nielsen, S. D. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1510-6 · Cited by 33
Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa
Sivro, A., McKinnon, L. R., Yende‐Zuma, N., Gengiah, S., Samsunder, N., Karim, S. S. A., & Naidoo, K. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix357 · Cited by 32
Combination Antiretroviral Therapy With Raltegravir Leads to Rapid Immunologic Reconstitution in Treatment-Naive Patients With Chronic HIV Infection
Pallikkuth, S., Fischl, M. A., & Pahwa, S. G. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit387 · Cited by 33
Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
Chastain, D. B., Henderson, H. M., & Stover, K. R. (2015) · The Open AIDS Journal · doi:10.2174/1874613601509010023 · Cited by 32
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study
Marchetti, G. C., Cozzi‐Lepri, A., Tincati, C., Calcagno, A., Ceccherini‐Silberstein, F., Luca, A. D., Antinori, A., Castagna, A., Puoti, M., & Monforte, A. D. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-79 · Cited by 31
New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144
Hernández-Walias, F. J., Ruiz-de-León, M. J., Rosado‐Sánchez, I., Vázquez, E., Leal, M., Moreno, S., Vidal, F., Blanco, J., Pacheco, Y. M., & Vallejo, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-60073-8 · Cited by 31
von Willebrand Factor is elevated in HIV patients with a history of thrombosis
van den Dries, L. V. D., Gruters, R., der Borden, S. B. C. H.-V., Kruip, M., de Maat, M. D., van Gorp, E. V., & van der Ende, M. E. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00180 · Cited by 28
Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression
Castillo‐Mancilla, J., Morrow, M., Boum, Y., Byakwaga, H., Haberer, J. E., Martin, J. N., Bangsberg, D. R., MaWhinney, S., Musinguzi, N., Huang, Y., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001629 · Cited by 31
Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection
Rhoades, N. S., Mendoza, N., Jankeel, A., Sureshchandra, S., Alvarez, A. D., Doratt, B. M., Heidari, O., Hagan, R., Brown, B. J., Scheibel, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00463 · Cited by 39
Initiation of antiretroviral therapy at high CD4 cell counts
Longenecker, C. T., & Triant, V. A. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000015 · Cited by 30
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
Ravimohan, S., Tamuhla, N., Steenhoff, A. P., Letlhogile, R., Makutu, D. K., Nfanyana, K., Rantleru, T., Tierney, A. M., Nkakana, K., Schwartz, A. B., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit368 · Cited by 31
The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth
Moscicki, A., Yao, T., Ryder, M. I., Russell, J. S., Dominy, S. S., Patel, K., McKenna, M., Dyke, R. B. V., Seage, G. R., Hazra, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156459 · Cited by 30
The association between plasma endotoxin, endotoxin pathway proteins and outcome after ischemic stroke
Klimiec, E., Pasińska, P., Kowalska, K., Pera, J., Słowik, A., & Dziedzic, T. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.034 · Cited by 30
Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity
Kumar, N. P., Moideen, K., Bhootra, Y., Nancy, A., Viswanathan, V., Shruthi, B. S., Sivakumar, S., Natarajan, M., Kornfeld, H., & Babu, S. (2018) · Immunology · doi:10.1111/imm.13023 · Cited by 30
Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIV
Jan, A. K., Moore, J. V., Wang, R. J., McGing, M., Farr, C. K., Moisi, D. D., Hartman-Filson, M., Kerruish, R., Jeon, D., Lewis, E., et al. (2021) · AIDS · doi:10.1097/qad.0000000000002846 · Cited by 31
The CD8+HLA‐DR+ T cells expanded in HIV‐1 infection are qualitatively identical to those from healthy controls
Imamichi, H., Lempicki, R. A., Adelsberger, J. W., Hasley, R. B., Rosenberg, A., Roby, G. A., Rehm, C. A., Nelson, A. K., Krishnan, S., Pavlick, M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142046 · Cited by 30
MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection
Huang, J., Zhu, L., Qiu, C., Xu, X., Zhang, L., Ding, X., Liao, Q., Xu, J., & Zhang, X. (2017) · Journal of Virology · doi:10.1128/jvi.02048-16 · Cited by 32
Assessment of Biomarkers of Cardiovascular Risk Among HIV Type 1-Infected Adolescents: Role of Soluble Vascular Cell Adhesion Molecule As an Early Indicator of Endothelial Inflammation
Syed, S. S., Balluz, R. S., Kabagambe, E. K., Meyer, W. A., Lukas, S., Wilson, C. M., Kapogiannis, B. G., Nachman, S., & Sleasman, J. W. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0086 · Cited by 30
Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV
Cioe, P. A., Baker, J. V., Kojic, E. M., Önen, N. F., Hammer, J., Patel, P., & Kahler, C. W. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000759 · Cited by 29
Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents
Alvarez, P., Mwamzuka, M., Marshed, F., Kravietz, A., Ilmet, T., Ahmed, A. A., Borkowsky, W., & Khaitan, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190332 · Cited by 29
HIV Therapy—The State of ART
Looney, D. J., Ma, A., & Johns, S. T. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_440 · Cited by 29
A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection
Dubé, M. P., Chan, E. S., Lake, J. E., Williams, B., Kinslow, J. D., LANDAY, A. L., Coombs, R. W., Floris-Moore, M., Ribaudo, H. J., & Yarasheski, K. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1051 · Cited by 29
Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis
Colomb, F., Giron, L. B., Trbojević‐Akmačić, I., Lauc, G., & Abdel‐Mohsen, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00433-w · Cited by 28
Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
Awoyemi, A., Trøseid, M., Arnesen, H., Solheim, S., & Seljeflot, I. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.05.004 · Cited by 30
Probiotics to manage inflammation in HIV infection
Reikvam, D. H., Meyer‐Myklestad, M. H., Trøseid, M., & Stiksrud, B. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000612 · Cited by 29
HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages
Akiyama, H., & Gummuluru, S. (2020) · Viruses · doi:10.3390/v12070711 · Cited by 30
Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection
Ferrari, B., Silva, A. C. D., Liu, K., Saidakova, E. V., Korolevskaya, L. B., Shmagel, K. V., Shive, C. L., Sánchez, G. P., Retuerto, M., Sharma, A. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci149571 · Cited by 29
Self-citation
New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals
Martin, H. A., Kadiyala, G. N., Telwatte, S., Wedrychowski, A., Chen, T., Morón‐López, S., Arneson, D., Hoh, R., Deeks, S. G., Wong, J. K., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01605-22 · Cited by 29
Self-citation
Reduced Immune Activation During Tenofovir–Emtricitabine Therapy in HIV-Negative Individuals
Castillo‐Mancilla, J., Meditz, A. L., Wilson, C. C., Zheng, J., Palmer, B. E., Lee, E. J., Gardner, E. M., Seifert, S. M., Kerr, B. J., Bushman, L. R., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000529 · Cited by 29
HIV-Infected Children Have Lower Frequencies of CD8+ Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets
Khaitan, A., Kilberg, M., Kravietz, A., Ilmet, T., Taştan, C., Mwamzuka, M., Marshed, F., Liu, M., Ahmed, A. A., Borkowsky, W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161786 · Cited by 29
Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Li, J. Z., Melberg, M., Kittilson, A., Abdel‐Mohsen, M., Li, Y., Aga, E., Bosch, R. J., Wonderlich, E. R., Kinslow, J. D., Giron, L. B., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.173864 · Cited by 28
Self-citation
Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial
Dirajlal‐Fargo, S., Musiime, V., Cook, A. D., Mirembe, G., Kenny, J. M., Jiang, Y., Debanne, S. M., Klein, N. J., & McComsey, G. A. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001544 · Cited by 28
Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection
Giron, L. B., Tanes, C., Schleimann, M. H., Engen, P. A., Mattei, L. M., Anzurez, A., Damra, M., Zhang, H., Bittinger, K. L., Bushman, F. D., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0279-5 · Cited by 31
Interferon-α alters host glycosylation machinery during treated HIV infection
Giron, L. B., Colomb, F., Papasavvas, E., Azzoni, L., Yin, X., Fair, M. G., Anzurez, A., Damra, M., Mounzer, K., Kostman, J. R., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102945 · Cited by 29
Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
Meyer‐Myklestad, M. H., Medhus, A. W., Lorvik, K. B., Seljeflot, I., Hansen, S. H., Holm, K., Stiksrud, B., Trøseid, M., Hov, J. R., Kvale, D., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa714 · Cited by 28
Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches
Brienze, V. M. S., André, J. C., Liso, E., & Louis, I. V.-S. (2021) · Life · doi:10.3390/life11020095 · Cited by 27
Association between serum soluble CD 14 and IL ‐8 levels and clinical outcome in primary biliary cholangitis
Umemura, T., Sekiguchi, T., Joshita, S., Yamazaki, T., Fujimori, N., Shibata, S., Ichikawa, Y., Komatsu, M., Matsumoto, A., Shums, Z., et al. (2016) · Liver International · doi:10.1111/liv.13316 · Cited by 28
Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation
Peterson, C. W., Benne, C., Polacino, P. S., Kaur, J., McAllister, C. E., Filali-Mouhim, A., Obenza, W., Pecor, T., Huang, M.-L. W., Baldessari, A. E., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91230 · Cited by 28
Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection
Mhandire, K., Mlambo, T., Zijenah, L. S., Duri, K., Mateveke, K., Tshabalala, M., Mhandire, D. Z., Musarurwa, C., Wekare, P. T., Mazengera, L. R., et al. (2017) · The Open AIDS Journal · doi:10.2174/1874613601711010024 · Cited by 28
Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers
Kim, C. J., Rousseau, R. K., Huibner, S., Kovacs, C. M., Benko, E., Shahabi, K., Kandel, G. P., Ostrowski, M., & Kaul, R. (2017) · AIDS · doi:10.1097/qad.0000000000001515 · Cited by 28
Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery
Gómez‐Mora, E., Massanella, M., García, E., Giles, D., Bernadó, M., Urrea, V., Carrillo, J., Ouchi, D., Puig, J., Negredo, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184433 · Cited by 28
Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection
Siedner, M. J., & Triant, V. A. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy445 · Cited by 28
The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy
Sortino, O., Hullsiek, K. H., Richards, E. S., Rupert, A. W., Schminke, A., Tetekpor, N., Quiñones, M., Prosser, R. A., Schacker, T., Sereti, I., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz042 · Cited by 28
Self-citation
Liver Stiffness Is Associated With Monocyte Activation in HIV-Infected Ugandans Without Viral Hepatitis
Redd, A. D., Wendel, S. K., Grabowski, M. K., Ocama, P., Kiggundu, V. L., Bbosa, F. F., Iga, B., Balagopal, A., Reynolds, S. J., Gray, R. H., et al. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0004 · Cited by 27
Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study
Peters, L., Neuhaus, J., Duprez, D. A., Neaton, J. D., Tracy, R. P., Klein, M. B., Mocroft, A., Rockstroh, J. K., Dore, G. J., & Lundgren, J. D. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.017 · Cited by 28
Self-citation
Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression
Thiébaut, R., Charpentier, C., Damond, F., Taïeb, A., Rachas, A., Capeau, J., Chêne, G., Collin, G., Matheron, S., Descamps, D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis708 · Cited by 27
Contribution of the Microbiota to Intestinal Homeostasis and its Role in the Pathogenesis of HIV-1 Infection
Luján, J., Rugeles, M. T., & Taborda, N. A. (2019) · Current HIV Research · doi:10.2174/1570162x17666190311114808 · Cited by 27
New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals
Pavlos, R. K., Deshpande, P., Chopra, A., Leary, S., Strautins, K., Nolan, D. A., Thorborn, D. E., Shaefer, M. S., Rauch, A., Dunn, D., et al. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.011 · Cited by 27
Soluble CD14 and Risk of Heart Failure and Its Subtypes in Older Adults
Al-Kindi, S. G., Bůžková, P., Shitole, S. G., Reiner, A. P., Garg, P. K., Gottdiener, J. S., Psaty, B. M., & Kizer, J. R. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.03.003 · Cited by 27
Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus
Schnittman, S. R., Deitchman, A. N., Beck‐Engeser, G., Ahn, H., York, V. A., Hartig, H. M., Hecht, F. M., Martin, J. N., Deeks, S. G., Aweeka, F. T., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa580 · Cited by 30
Self-citation
Potential biomarkers for the early prediction of SARS-COV-2 disease outcome
Mariappan, V., Manoharan, P. S., Ranganadin, P., Lokesh, S., Rao, S. R., & Pillai, A. B. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105057 · Cited by 27
Menopause Is Associated With Immune Activation in Women With HIV
Peters, B. A., Xue, X., Sheira, L. A., Qi, Q., Sharma, A., Santoro, N. F., Alcaide, M. L., Ofotokun, I., Adimora, A. A., McKay, H., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab341 · Cited by 27
C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings
Tenforde, M. W., Gupte, N., Dowdy, D. W., Asmuth, D. M., Balagopal, A., Pollard, R. B., Sugandhavesa, P., Lama, J. R., Pillay, S., Cardoso, S. W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117424 · Cited by 28
Microbial Translocation and Metabolic and Body Composition Measures in Treated and Untreated HIV Infection
Timmons, T., Shen, C., Aldrovandi, G. M., Rollie, A., Gupta, S. K., Stein, J. H., & Dubé, M. P. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0162 · Cited by 27
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone
Utay, N. S., Kitch, D. W., Yeh, E., Fichtenbaum, C. J., Lederman, M. M., Estes, J. D., Deléage, C., Magyar, C. E., Nelson, S. D., Klingman, K. L., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy064 · Cited by 27
Self-citation
Amino Acid Concentrations in HIV-Infected Youth Compared to Healthy Controls and Associations with CD4 Counts and Inflammation
Ziegler, T. R., Judd, S. E., Ruff, J. H., McComsey, G. A., & Eckard, A. R. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0369 · Cited by 28
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Gonzalez‐Cordón, A., Assoumou, L., Moyle, G. J., Waters, L. J., Johnson, M. A., Domingo, P., Fox, J., Stellbrink, H., Guaraldi, G., Masiá, M., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab158 · Cited by 27
Systemic Immune Activation and Microbial Translocation in Dual HIV/Tuberculosis-Infected Subjects
Toossi, Z., Funderburg, N., Sirdeshmuk, S., Whalen, C. C., Nanteza, M. W., Johnson, D. F., Mayanja‐Kizza, H., & Hirsch, C. S. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit092 · Cited by 27
Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans
Seu, L., Burt, T. D., Witte, J. S., Martin, J. N., Deeks, S. G., & McCune, J. M. (2012) · Genes & Immunity · doi:10.1038/gene.2011.76 · Cited by 26
Self-citation
Abnormal Bone Acquisition With Early-Life HIV Infection: Role of Immune Activation and Senescent Osteogenic Precursors
Manavalan, J. S., Arpadi, S. M., Tharmarajah, S., Shah, J., Zhang, C. A., Foca, M. D., Neu, N. M., Bell, D. L., Nishiyama, K. K., Kousteni, S., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2883 · Cited by 26
Alterations in circulating markers in HIV/AIDS patients with poor immune reconstitution: Novel insights from microbial translocation and innate immunity
Xiao, Q., Yu, F., Yan, L., Zhao, H., & Zhang, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1026070 · Cited by 28
Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection
Funderburg, N., Shive, C. L., Chen, Z., Tatsuoka, C. M., Bowman, E., Longenecker, C. T., McComsey, G. A., Clagett, B. M., Dorazio, D., Freeman, M. L., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad199 · Cited by 26
Neutrophil-inspired photothermo-responsive drug delivery system for targeted treatment of bacterial infection and endotoxins neutralization
Li, C., Gan, Y., Li, Z., Fu, M., Li, Y., Peng, X., Yang, Y., Tian, G., Yang, Y. Y., Yuan, P., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00372-z · Cited by 26
Gene Array Studies in HIV-1 Infection
Mehla, R., & Ayyavoo, V. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0100-x · Cited by 26
The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation
Wallet, M. A., Reist, C. M., Williams, J., Appelberg, S., Guiulfo, G., Gardner, B., Sleasman, J. W., & Goodenow, M. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0911447 · Cited by 26
A cure for HIV: is it in sight?
Pace, M. J., & Frater, J. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.910112 · Cited by 26
Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients
Overton, E. T., Sterrett, S., Westfall, A. O., Kahan, S. M., Burkholder, G., Zajac, A. J., Goepfert, P., & Bansal, A. (2014) · AIDS · doi:10.1097/qad.0000000000000475 · Cited by 26
HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system
Guedia, J., Brun, P., Bhave, S. M., Fitting, S., Kang, M., Dewey, W. L., Hauser, K. F., & Akbarali, H. I. (2016) · Scientific Reports · doi:10.1038/srep31203 · Cited by 26
Alterations of the gut bacterial microbiota in rhesus macaques with SIV infection and on short- or long-term antiretroviral therapy
Siddiqui, S., Bao, D., Doyle‐Meyers, L. A., Dufour, J., Wu, Y., Liu, Y., & Ling, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-76145-8 · Cited by 26
Association between alcohol use and inflammatory biomarkers over time among younger adults with HIV—The Russia ARCH Observational Study
So‐Armah, K., Cheng, D. M., Freiberg, M. S., Gnatienko, N., Patts, G. J., Ma, Y., White, L. F., Blokhina, E. A., Lioznov, D. A., Doyle, M. F., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219710 · Cited by 25
HIV and comorbidities – the importance of gut inflammation and the kynurenine pathway
MacCann, R., LANDAY, A. L., & Mallon, P. W. G. (2022) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000782 · Cited by 27
Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
Nowak, P., Abdurahman, S., Lindkvist, A., Trøseid, M., & Sönnerborg, A. B. (2012) · International Journal of Microbiology · doi:10.1155/2012/263836 · Cited by 25
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case–Cohort Study
Balagopal, A., Asmuth, D. M., Yang, W.-T., Campbell, T., Gupte, N., Smeaton, L. M., Kanyama, C., Grinsztejn, B. G. J., Santos, B. R., Supparatpinyo, K., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000696 · Cited by 25
Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy
Ticona, E., Bull, M. E., Soria, J., Tapia, K. A., Legard, J., Styrchak, S. M., Williams, C. M., Mitchell, C. M., Rosa, A. L., Coombs, R. W., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000758 · Cited by 25
Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption
Dross, S., Munson, P. V., Kim, S. E., Bratt, D., Tunggal, H. C., Gervassi, A. L., FULLER, D. H., & Horton, H. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600759 · Cited by 25
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection
Mascia, C., Lichtner, M., Zuccalà, P., Vita, S., Tieghi, T., Marocco, R., Savinelli, S., Rossi, R., Iannetta, M., Campagna, M., et al. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.04.007 · Cited by 25
Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection
Novelli, S., Lécuroux, C., Avettand-Fènoël, V., Seng, R., Essat, A., Morlat, P., Viard, J., Rouzioux, C., Meyer, L., & Goujard, C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1068 · Cited by 29
Assessing Statin Effects on Cardiovascular Pathways in HIV Using a Novel Proteomics Approach: Analysis of Data from Intrepid, a Randomized Controlled Trial
Toribio, M. P., Fitch, K. V., Stone, L. A., Zanni, M. V., Lo, J., de Filippi, C., Sponseller, C. A., Lee, H., Grundberg, I., Thompson, M., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.039 · Cited by 26
Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
Funderburg, N., McComsey, G. A., Kulkarni, M., Bannerman, T. L., Mantini, J., Thornton, B., Liu, H. C., Zhang, Y., Song, Q., Fang, L., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.009 · Cited by 25
Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities
Sainz, T., Díaz, L., Navarro, M. L., Rojo, P., Blázquez‐Gamero, D., Ramos, J. T., de José, M. I., Álvarez-Fuente, M., Villar, S. S., Mellado, M. J., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.025 · Cited by 24
FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children
Khaitan, A., Kravietz, A., Mwamzuka, M., Marshed, F., Ilmet, T., Said, S., Ahmed, A. A., Borkowsky, W., & Unutmaz, D. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001000 · Cited by 24
HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication
Appelberg, K. S., Wallet, M. A., Taylor, J. P., Cash, M. N., Sleasman, J. W., & Goodenow, M. M. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0273 · Cited by 25
Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV
Kettelhut, A., Bowman, E., & Funderburg, N. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00509-y · Cited by 24
The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia
Dzikowski, M., Juchnowicz, D., Dzikowska, I., Róg, J., Próchnicki, M., Kozioł, M. M., & Karakuła‐Juchnowicz, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113707 · Cited by 24
Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve Patients
Liu, K., Huang, H.-H., Yang, T., Jiao, Y., Zhang, C., Song, J., Zhang, J., Zhou, C., Yuan, J., Cao, W., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670616 · Cited by 24
Mucosal‐associated invariant T cells: A cryptic coordinator in HIV‐infected immune reconstitution
Su, B., Kong, D., Yang, X., Zhang, T., & Kuang, Y. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27696 · Cited by 24
Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir
Clercq, J. D., Scheerder, M. D., Mortier, V., Verhofstede, C., Vandecasteele, S. J., Allard, S. D., Necsoi, C., Wit, S. D., Gerlo, S., & Vandekerckhove, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1337316 · Cited by 26
Relationship Between Poor Physical Function, Inflammatory Markers, and Comorbidities in HIV-Infected Women on Antiretroviral Therapy
Baranoski, A. S., Harris, A., Michaels, D., Miciek, R., Storer, T. W., Paola Sebastiani, B., & Montano, M. A. (2013) · Journal of Women s Health · doi:10.1089/jwh.2013.4367 · Cited by 22
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens
Asmuth, D. M., Ma, Z.-M., Mann, S. K., Knight, T. H., Yotter, T., Albanese, A. P., MELCHER, G. P., Troia-Cancio, P. V., Hayes, T., Miller, C. J., et al. (2012) · AIDS · doi:10.1097/qad.0b013e3283546595 · Cited by 24
Assessing risk of a short‐term antiretroviral therapy discontinuation as a read‐out of viral control in immune‐based therapy
Routy, J., Boulassel, M., Nicolette, C. A., & Jacobson, J. M. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23297 · Cited by 24
CD8 T-Cell Activation Is Associated With Lipodystrophy and Visceral Fat Accumulation in Antiretroviral Therapy–Treated Virologically Suppressed HIV-Infected Patients
Guaraldi, G., Luzi, K., Bellistrì, G. M., Zona, S., da Silva, A. R. D., Bai, F., Garlassi, E., Marchetti, G. C., Capeau, J., & Monforte, A. D. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000001 · Cited by 24
Immunovirological parameters and cytokines in HIV infection
Tasca, K. I., Calvi, S. A., & de Souza, L. D. R. (2012) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822012000600002 · Cited by 24
Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age‐matched controls: Role of cytomegalovirus
Azanan, M. S., Abdullah, N. K., Chua, L. L., Lum, S. H., Ghafar, S. S. A., Kamarulzaman, A., Kamaruzzaman, S. B., Lewin, S. R., Woo, Y. L., Ariffin, H., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201646356 · Cited by 24
Self-citation
Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization
Study, T. S. H. C., Cecchinato, V., Bernasconi, E., Speck, R. F., Proietti, M., Sauermann, U., D’Agostino, G., Danelon, G., Jost, T. R., Grassi, F., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600568 · Cited by 24
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: Possible implication for TLR4-signalling and chronic immune activation
Trøseid, M., Lind, A., Nowak, P., Barqasho, B., Heger, B., Lygren, I., Pedersen, K. K., Kanda, T., Funaoka, H., Damås, J. K., et al. (2012) · Innate Immunity · doi:10.1177/1753425912461042 · Cited by 24
Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation
Shivakoti, R., Yang, W.-T., Gupte, N., Berendes, S., Rosa, A. L., Cardoso, S. W., Mwelase, N., Kanyama, C., Pillay, S., Samaneka, W. P., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ265 · Cited by 26
Evaluation of Six Weekly Oral Fecal Microbiota Transplants in People with HIV
Utay, N. S., Monczor, A. N., Somasunderam, A., Lupo, S., Jiang, Z., Alexander, A. S., Finkelman, M., Vigil, K. J., Lake, J. E., Hanson, B., et al. (2020) · Pathogens and Immunity · doi:10.20411/pai.v5i1.388 · Cited by 23

Authors: Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., Neaton, J. D., Brenchley, J. M., Deeks, S. G., Sereti, I., & Douek, D. C.
Affiliations: UNSW Sydney (AU)
National Institutes of Health (US)
Virginia Commonwealth University (US)
University of Southern Denmark (DK)
Chulalongkorn University (TH)
Burnet Institute (AU)
University of Minnesota (US)
San Francisco General Hospital (US)
ORCID: Wand, Handan
Law, Matthew
Nason, Martha C.
Ruxrungtham, Kiat
Lewin, Sharon R.
Emery, Sean
Neaton, James D.
Brenchley, Jason M.
Deeks, Steven G.
Sereti, Irini
Douek, Daniel C.
Venue: The Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2011-03-15
Volume: 203
Issue: 6
Pages: 780-790
ISSN: 0022-1899 (ISSN-L)
1537-6613
DOI: 10.1093/infdis/jiq118
PMC: PMC3071127
OpenAlex: W2098152094
Cited by: 1,106
References: 50
Citations by year: 2026: 32 · 2025: 31 · 2024: 59 · 2023: 48 · 2022: 67 · 2021: 70 · 2020: 76 · 2019: 70 · 2018: 69 · 2017: 83 · 2016: 107 · 2015: 97 · 2014: 111 · 2013: 93 · 2012: 65
FWCI: 37.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Infectious Diseases (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Funders: National Center for Genetic Engineering and Biotechnology
National Institutes of Health
National Institute of Allergy and Infectious Diseases (AI 76174, P01AI076174)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: soluble CD14, HIV infection, mortality prediction, microbial translocation, intestinal permeability, lipopolysaccharide, endotoxin core antibody, intestinal fatty acid binding protein, cardiovascular disease, AIDS, innate immune activation, SMART trial, prognostic factors
MeSH terms: Adult, Cause of Death, Humans, Lipopolysaccharides, Male, Middle Aged, RNA, Viral, Biomarkers, CD4-Positive T-Lymphocytes, HIV Infections, Logistic Models, Case-Control Studies, Lipopolysaccharide Receptors, Fatty Acid-Binding Proteins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks